Controlled Ovarian Stimulation and Human Uterine Lavage

P

Previvo Genetics

Status

Unknown

Conditions

Infertility, Female

Treatments

Procedure: Uterine lavage

Study type

Interventional

Funder types

Industry

Identifiers

NCT03426007
TD-2104

Details and patient eligibility

About

This is a feasibility study intended to demonstrate the Previvo Uterine Lavage System's ability to recover embryos from the uterus following either natural cycle (NC)/intrauterine insemination (IUI), or controlled ovarian hyperstimulation (COH)/intrauterine insemination (IUI).

Full description

The study is a prospective, multi- center, multiple-arm, feasibility study to evaluate the safety and efficacy of the Previvo System in the recovery of embryos. This study will recruit up to 500 healthy premenopausal volunteers. Subjects will undergo either natural cycle (NC)/intrauterine insemination (IUI), or controlled ovarian hyperstimulation (COH)/intrauterine insemination (IUI) and have the lavage procedure performed 4-6 days post IUI. It is anticipated that embryos recovered will be cryopreserved for future use or donated for future use. Subjects will be followed up with for up to 30 days after the lavage procedure. All data will be collected on paper CRFs and analyzed by the Principal Investigator and Study Sponsor.

Enrollment

500 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Premenopausal female 18-40 years of age
  2. Physically healthy and reasonably healthy family medical history
  3. Having both ovaries with patent fallopian tubes, no known reproductive problems
  4. BMI between 18-35 Kg/m2
  5. Presence of a normal uterine cavity as assessed by sonohysterogram (SHG), hysterosalpingogram (HSG), or ultrasound
  6. Evidence of normal uterine anatomy that would not prevent the introduction of the lavage catheter.

Exclusion criteria

  1. History of, or presence of hydrosalpinx

  2. Addiction to alcohol and/or narcotics

  3. Had radiotherapy or chemotherapy

  4. Existence of an ovarian cyst at the beginning of cycle with suspicion of malignancy or a large benign cyst

  5. Contraindication for oral contraceptive pills or other study medication

  6. Clinically significant abnormal basic metabolic panel lab results

  7. Positive test or history of any of the following conditions:

    1. Human immunodeficiency virus (HIV)
    2. Hepatitis B infection
    3. Hepatitis C infection
    4. Syphilis (RPR)
    5. Chlamydial pelvic infection
    6. Gonorrheal pelvic infection.
    7. Positive Pregnancy Test
  8. Prior IUD for 60 days or less, or one currently in place

  9. Allergic to study materials, supplies and medication

  10. Any active, uncontrolled, clinically significant medical condition as determined by the treating principal investigator

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 1 patient group

Uterine Lavage
Experimental group
Description:
Embryo recovery from the uterus following either natural cycle (NC)/intrauterine insemination (IUI), or controlled ovarian hyperstimulation (COH)/intrauterine insemination (IUI).
Treatment:
Procedure: Uterine lavage

Trial contacts and locations

1

Loading...

Central trial contact

Gheda Sahyun, MA; Alex Nidal

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems